C24H44Cl2N2O4Sn4, orthorhombic, Pbca (no. 61), a = 13.9593(2) Å, b = 11.1227(2) Å, c = 21.6656(3) Å, V = 3363.91(9) Å3, Z = 4, Rgt(F) = 0.0252, wRref(F2) = 0.0642, T = 100(2) K
In the title co-crystal, [Sn4(CH3)8Cl4O2]·2[Sn(CH3)2Cl(C4H8NS2)], all the SnIV atoms are in...
C52H48N4O10Sn2, triclinic, P1̄ (no. 2), a = 8.4845(1) Å, b = 9.2814(1) Å, c = 15.5517(2) Å, α = 83.0...
The asymmetric unit of the title compound, [Sn4(C7H6Cl)8(C8H7O2)2O2(OH)2], comprises one-half of the...
C84H52Cl8F16O10Sn4, triclinic, P1̄ (no. 2), a = 11.2999(9) Å, b = 14.1471(11) Å, c = 15.2378(12) Å, ...
C54H50Cl4O2P2Sn, triclinic, P1̄ (no. 2), a = 10.6360(2) Å, b = 10.8406(2) Å, c = 12.5727(2) Å, α = 9...
C37H29ClO4Sn, monoclinic, P21/c (no. 14), a = 10.4233(3) Å, b = 19.5060(6) Å, c = 14.8084(5) Å, β = ...
C30H44N2O4Sn2, monoclinic, P21/c, a = 8.8810(8) Å, b = 16.8999(13) Å, c = 10.5705(10) Å, β = 92.0460...
C24H22ClNOSn, monoclinic, P21/c (no. 14), a = 13.7584(1) Å, b = 13.5542(1) Å, c = 13.0912(1) Å, β = ...
C10H17ClN2O10Sn, triclinic, P1 (no. 1), a = 6.6666(3) Å, b = 6.6892(4) Å, c = 8.8779(6) Å, α = 101.3...
In the title compound, [Sn4(CH3)8(C8H9O2)2Cl2O2], the tetranuclear complex molecule has crystallogra...
C24H22Cl2N2O2Sn, monoclinic, P21/n (no. 14), a = 12.6418(1) Å, b = 13.2422(1) Å, c = 13.6364(1) Å, β...
[C28H24Cl4Sn], orthorhombic, Fdd2 (no. 43), a = 22.01600(10) Å, b = 20.79690(10) Å, c = 11.15230(10)...
C8H18ClNS2Sn, triclinic, P1̄ (no. 2), a = 6.4399(2) Å, b = 9.6430(3) Å, c = 11.6944(1) Å, α = 91.966...
In the centrosymmetric tetranuclear title complex, [Sn4(C4H9)8(C3H3Br2O2)4O2], one of the two indepe...
C13H19ClN2S2Sn, triclinic, P1̄ (no. 2), a = 6.5837(2) Å, b = 9.9458(2) Å, c = 12.8720(3) Å, α = 85.3...
In the title co-crystal, [Sn4(CH3)8Cl4O2]·2[Sn(CH3)2Cl(C4H8NS2)], all the SnIV atoms are in...
C52H48N4O10Sn2, triclinic, P1̄ (no. 2), a = 8.4845(1) Å, b = 9.2814(1) Å, c = 15.5517(2) Å, α = 83.0...
The asymmetric unit of the title compound, [Sn4(C7H6Cl)8(C8H7O2)2O2(OH)2], comprises one-half of the...
C84H52Cl8F16O10Sn4, triclinic, P1̄ (no. 2), a = 11.2999(9) Å, b = 14.1471(11) Å, c = 15.2378(12) Å, ...
C54H50Cl4O2P2Sn, triclinic, P1̄ (no. 2), a = 10.6360(2) Å, b = 10.8406(2) Å, c = 12.5727(2) Å, α = 9...
C37H29ClO4Sn, monoclinic, P21/c (no. 14), a = 10.4233(3) Å, b = 19.5060(6) Å, c = 14.8084(5) Å, β = ...
C30H44N2O4Sn2, monoclinic, P21/c, a = 8.8810(8) Å, b = 16.8999(13) Å, c = 10.5705(10) Å, β = 92.0460...
C24H22ClNOSn, monoclinic, P21/c (no. 14), a = 13.7584(1) Å, b = 13.5542(1) Å, c = 13.0912(1) Å, β = ...
C10H17ClN2O10Sn, triclinic, P1 (no. 1), a = 6.6666(3) Å, b = 6.6892(4) Å, c = 8.8779(6) Å, α = 101.3...
In the title compound, [Sn4(CH3)8(C8H9O2)2Cl2O2], the tetranuclear complex molecule has crystallogra...
C24H22Cl2N2O2Sn, monoclinic, P21/n (no. 14), a = 12.6418(1) Å, b = 13.2422(1) Å, c = 13.6364(1) Å, β...
[C28H24Cl4Sn], orthorhombic, Fdd2 (no. 43), a = 22.01600(10) Å, b = 20.79690(10) Å, c = 11.15230(10)...
C8H18ClNS2Sn, triclinic, P1̄ (no. 2), a = 6.4399(2) Å, b = 9.6430(3) Å, c = 11.6944(1) Å, α = 91.966...
In the centrosymmetric tetranuclear title complex, [Sn4(C4H9)8(C3H3Br2O2)4O2], one of the two indepe...
C13H19ClN2S2Sn, triclinic, P1̄ (no. 2), a = 6.5837(2) Å, b = 9.9458(2) Å, c = 12.8720(3) Å, α = 85.3...
In the title co-crystal, [Sn4(CH3)8Cl4O2]·2[Sn(CH3)2Cl(C4H8NS2)], all the SnIV atoms are in...
C52H48N4O10Sn2, triclinic, P1̄ (no. 2), a = 8.4845(1) Å, b = 9.2814(1) Å, c = 15.5517(2) Å, α = 83.0...
The asymmetric unit of the title compound, [Sn4(C7H6Cl)8(C8H7O2)2O2(OH)2], comprises one-half of the...
DOI
Add to ORKG